UNAIDS calls on countries to support community-led / based initiatives and adopt a new set of bold, yet achievable HIV targets, including in relation to repealing destructive criminalising laws.
Wolfe and Saucier argue that the success of future biotechnological treatments will rely on how the ethical considerations behind its applications will be addressed.
The HIV Policy Lab shines a light on policy barriers in access to high-quality HIV treatment and prevention, a key driver of new transmissions and deaths.
Youth RISE highlights high rates of trauma in young people in touch with the criminal justice system, underscoring the importance of trauma-informed services.
Betsos et al. demonstrate that drug sellers used information from drug checking to minimise the harms associated with fentanyl and maintain trust with their clients.
The WOLA provides policy recommendations for developing and implementing gender-sensitive drug and prison-related policies rooted in human rights and public health.
GDPO provides a critical reading of 'development-orientated drug policies', underscoring the importance of focusing on the socio-structural drivers of involvement in illicit drug markets.
The HIV Legal Network urges local authorities to use flexibilities within their power to undo the damage of criminalisation on people who use drugs, until legislation is changed federally.
IDPC, WOLA and PRI note an alarming rise in female incarceration rates in Latin America since 2000, putting countless women at risk of abuse and exacerbating the vulnerabilities they face in society.
OPIS argues evidence for the therapeutic potential of psilocybin in addressing this debilitating condition warrants immediate reform to allow for legal access and further research.
